Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases

Brain Research Bulletin

Volumn 55, Issue 2, 2001, Pages 175-185

  Strausak, Daniel ^a,b   Mercer, Julian F B ^a   Dieter, Hermann H ^c   Stremmel, Wolfgang ^b   Multhaup, Gerd ^b  

^a DEAKIN UNIVERSITY   (Australia)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UMWELTBUNDESAMT   (Germany)

Author keywords

Alzheimer's disease; Copper; Menkes; Neurodegeneration; Wilson

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CATECHOLAMINE; COPPER ION; CYTOCHROME; CYTOCHROME C OXIDASE; DOPAMINE BETA MONOOXYGENASE; OXYGEN; SUPEROXIDE DISMUTASE; WATER; ZINC ION;

AKINESIA; ALZHEIMER DISEASE; BIOSYNTHESIS; BRAIN DYSFUNCTION; CELL RESPIRATION; CONFERENCE PAPER; DEPRESSION; DISEASE SEVERITY; DYSTONIA; EPIDEMIOLOGY; FEEDING DISORDER; HOMEOSTASIS; HUMAN; ION TRANSPORT; MENKES SYNDROME; MENTAL DEFICIENCY; MUSCLE HYPOTONIA; NERVE DEGENERATION; NEUROLOGIC DISEASE; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; REDUCTION; SEIZURE; WILSON DISEASE;

ALZHEIMER DISEASE; ANIMALS; BRAIN; COPPER; ENZYMES; HEPATOLENTICULAR DEGENERATION; HOMEOSTASIS; HUMANS; MENKES KINKY HAIR SYNDROME; METALLOPROTEINS; NERVE DEGENERATION;

EID: 0035872487     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00454-3     Document Type: Conference Paper

References (170)

1. Expression of Menkes disease gene in mammary carcinoma cells
2. The cytopathology of metal overload
3. Ultrastructure of brain and nerve biopsy tissue in Wilson disease
4. Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease
5. Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis
6. Uptake of 67copper complexed to 3H-histidine by brain hypothalamic slices: Evidence that dissociation of the complex is not the only factor determining 67copper uptake
7. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease
8. It all sticks together - The APP-related family of proteins and Alzheimer's disease
9. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
10. Promotion of transition metal-induced reactive oxygen species formation by beta-amyloid
11. Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion
12. A novel pineal night-specific ATPase encoded by the Wilson disease gene
13. The copper hypothesis of schizophrenia: A review
14. Wilson disease
15. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene
16. A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease
17. Rapid induction of Alzheimer A beta amyloid formation by zinc
18. The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily
19. X-linked cutis laxa: Defective cross-link formation in collagen due to decreased lysyl oxidase activity
20. Recombinant human amyloid precursor-like protein 2 (APLP2) expressed in the yeast Pichia pastoris can stimulate neurite outgrowth
21. Cloning the Wilson disease gene
22. Aqueous dissolution of Alzheimer's disease abeta amyloid deposits by biometal depletion
23. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain
24. Menkes' kinky hair disease: Further definition of the defect in copper transport
25. Similar splicing mutations of the Menkes/mottled copper-transporting ATPase gene in occipital horn syndrome and the blotchy mouse
26. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: Possible relation to oxidative stress
27. Copper-induced conformational changes in the N-terminal domain of the Wilson disease copper-transporting ATPase
28. Copper transport and its alterations in Menkes and Wilson diseases
29. Immunocytochemical localization of the Menkes copper transport protein (ATP7A) to the trans-Golgi network
30. Adenosine triphosphate-dependent copper transport in human liver
31. Amyloid beta peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides
32. Mitochondrial encephalomyopathies
33. Brain trace elements in Alzheimer's disease
34. Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant?
35. Identification of a di-leucine motif within the C terminus domain of the Menkes disease protein that mediates endocytosis from the plasma membrane
36. A Golgi localization signal identified in the Menkes recombinant protein
37. Neurobiology of zinc and zinc-containing neurons
38. The role of glutathione in copper metabolism and toxicity
39. Trichopoliodystrophy. I. Report of a case and biochemical studies
40. Sequence, mapping and disruption of CCC2, a gene that cross-complements the Ca(2+)-sensitive phenotype of csg1 mutants and encodes a P-type ATPase belonging to the Cu(2+)-ATPase subfamily
41. Variability in clinical expression of Menkes syndrome
42. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovasculaar amyloid protein
43. Oxidative-phosphorylation defects in liver of patients with Wilson's disease
44. Amyloid beta-peptide is produced by cultured cells during normal metabolism
45. Interaction of the copper chaperone HAH1 with the Wilson disease protein is essential for copper homeostasis
46. Role of ATP7B in biliary copper excretion in a human hepatoma cell line and normal rat hepatocytes
47. Characterisation of copper-binding to the second sub-domain of the Menkes protein ATPase (MNKr2)
48. Deficiency of copper can cause neuronal degeneration
49. Brain tissue accumulates 67copper by two ligand-dependent saturable processes. A high affinity, low capacity and a low affinity, high capacity process
50. Evidence for release of copper in the brain: Depolarization-induced release of newly taken-up 67copper
51. Evidence for Cu(II) reduction as a component of copper uptake by Saccharomyces cerevisiae
52. Expression of human amyloid precursor protein ectodomains in Pichia pastoris: Analysis of culture conditions, purification, and characterization
53. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease
54. The beta A4 amyloid precursor protein binding to copper
55. Menkes X-linked disease: Prenatal diagnosis of hemizygous males and heterozygous females
56. The pathology and trace element status of the toxic milk mutant mouse
57. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction
58. Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors
59. Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction
60. Energetics of copper trafficking between the Atx1 metallochaperone and the intracellular copper transporter, Ccc2
61. Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae
62. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
63. A case of Wilson's disease with enormous cavity formation of cerebral white matter
64. Cooperative binding of copper(I) to the metal binding domains in Menkes disease protein
65. Plasma and cerebrospinal fluid neurochemical pattern in Menkes disease
66. Prenatal diagnosis of Menkes disease
67. Nerve endings from rat brain tissue release copper upon depolarization. A possible role in regulating neuronal excitability
68. Identification and functional expression of HAH1, a novel human gene involved in copper homeostasis
69. Does CSF copper level in Wilson disease reflect copper accumulation in the brain?
70. Clinical and biochemical consequences of copper-histidine therapy in Menkes disease
71. Correction of the copper transport defect of Menkes patient fibroblasts by expression of the Menkes and Wilson ATPases
72. Neurotoxic effects of copper: Inhibition of glycolysis and glycolytic enzymes
73. Fatal deterioration of Wilson's disease after institution of oral zinc therapy
74. Characterization of the interaction between the Wilson and Menkes disease proteins and the cytoplasmic copper chaperone, HAH1p
75. Skeletal dysplasia, occipital horns, diarrhea and obstructive uropathy - A new hereditary syndrome
76. Histochemically reactive zinc in plaques of the Swedish mutant beta-amyloid precursor protein transgenic mice
77. Differential effects of olanzapine on the gene expression of superoxide dismutase and the low affinity nerve growth factor receptor
78. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders
79. Copper, iron and zinc in Alzheimer's disease senile plaques
80. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease
81. Localization of the Wilson's disease protein product to mitochondria
82. Cytochrome c oxidase deficiency in Menkes kinky hair disease
83. Neuronal origin of a cerebral amyloid: Neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels
84. Amyloid plaque core protein in Alzheimer disease and Down syndrome
85. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein
86. Diagnosis of Wilson's disease presenting as fulminant hepatic failure
87. Kinky hair disease: Twenty five years later
88. Isolation of a partial candidate gene for Menkes disease by positional cloning
89. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth
90. The LEC rat: A model for human hepatitis, liver cancer, and much more
91. Schizophrenia-like symptoms in the Westphal-Strumpell variation of Wilson disease
92. Protection of flupirtine on beta-amyloid-induced apoptosis in neuronal cells in vitro: Prevention of amyloid-induced glutathione depletion
93. Identification and regulation of the high affinity binding site of the Alzheimer's disease amyloid protein precursor (APP) to glycosaminoglycans
94. Interaction between the zinc (II) and the heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP)
95. Autoxidation of amyloid precursor protein and formation of reactive oxygen species
96. Metal binding and radical generation of proteins in human neurological diseases and aging
97. Reactive oxygen species and Alzheimer's disease
98. Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide
99. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)
100. Intracellular distribution of the Wilson's disease gene product (ATPase7B) after in vitro and in vivo exogenous expression in hepatocytes from the LEC rat, an animal model of Wilson's disease
101. Primary structure of two P-type ATPases involved in copper homeostasis in Enterococcus hirae
102. Serum copper in schizophrenia in Nigerians
103. Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies
104. Deterioration of Wilson's disease following the start of penicillamine therapy
105. Functional expression of the menkes disease protein reveals common biochemical mechanisms among the copper-transporting P-type ATPases
106. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia
107. A C-terminal di-leucine is required for localization of the Menkes protein in the trans-Golgi network
108. Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: A novel mechanism of regulated trafficking
109. Tau is a candidate gene for chromosome 17 frontotemporal dementia
110. A Menkes P-type ATPase involved in copper homeostasis in the central nervous system of the rat
111. Brain iron and neurological disorders
112. Neuropsychological aspects of Wilson's disease
113. Abnormalities of copper in Gilles de la Tourette syndrome
114. Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion
115. Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease
116. Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue
117. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
118. Copper metabolism in mottled mouse mutants. The effect of copper therapy on lysyl oxidase activity in brindled (Mobr) mice
119. Cysteine 144 is a key residue in the copper reduction by the beta-amyloid precursor protein
120. Immunohistochemical determination of the Wilson Copper-transporting P-type ATPase in the brain tissues of the rat
121. Caenorhabditis elegans cDNA for a Menkes/Wilson disease gene homologue and its function in a yeast CCC2 gene deletion mutant
122. Elemental imbalances in the olfactory pathway in Alzheimer's disease
123. Similar alternative splicing of a non-homologous domain in beta A4-amyloid protein precursor-like proteins
124. Life-span and Menkes kinky hair syndrome: Report of a 13-year course of this disease
125. Early copper histidine therapy in classic Menkes disease
126. Hepatocyte-specific localization and copper-dependent trafficking of the Wilson's disease protein in the liver
127. Localization of the Wilson's disease protein in human liver
128. Characterization of an amyloid beta precursor protein that binds heparin and contains tyrosine sulfate
129. Alzheimer's disease: Genotypes, phenotypes, and treatments
130. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease
131. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids
132. Production of the Alzheimer amyloid beta protein by normal proteolytic processing
133. Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP)
134. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
135. CPx-type ATPases: A class of P-type ATPases that pump heavy metals
136. Cytochrome C oxidase deficiency and neuronal involvement in Menkes' kinky hair disease: Immunohistochemical study
137. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
138. Molecular cloning of the cDNA for a human amyloid precursor protein homolog: Evidence for a multigene family
139. The role of GMXCXXC metal binding sites in the copper-induced redistribution of the Menkes protein
140. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients
141. A comparison of copper-loading disease in Bedlington terriers and Wilson's disease in humans
142. Regional distribution of copper, zinc and iron in the brain in Long- Evans Cinnamon (LEC) rats with a new mutation causing hereditary hepatitis
143. Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains
144. An etiological role of amyloidogenic carboxyl-terminal fragments of the beta-amyloid precursor protein in Alzheimer's disease
145. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene
146. Regional brain trace-element studies in Alzheimer's disease
147. Prenatal and postnatal diagnosis of Menkes disease, an inherited disorder of copper metabolism
148. Identification of point mutations in 41 unrelated patients affected with Menkes disease
149. Clinical, morphologic, and chemical studies on copper toxicosis of Bedlington Terriers
150. Neurologic changes in liver disease
151. Characterization of beta-amyloid peptide from human cerebrospinal fluid
152. Functional analysis of the N-terminal CXXC metal-binding motifs in the human menkes copper-transporting P-type ATPase expressed in cultured mammalian cells
153. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase
154. The role of copper in neurodegenerative disease
155. Brain copper in Wilson's disease
156. Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor
157. CSF copper concentration: A new parameter for diagnosis and monitoring therapy of Wilson's disease with cerebral manifestation
158. Structural basis for copper transfer by the metallochaperone for the Menkes/Wilson disease proteins
159. The Alzheimer's disease amyloid precursor protein (APP) modulates copper-induced toxicity and oxidative stress in primarya neuronal cultures
160. Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice
161. Survival of cultured neurons from amyloid precursor protein knock-out mice against Alzheimer's amyloid-beta toxicity and oxidative stress
162. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene
163. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease
164. Expression of the Wilson disease gene is deficient in the Long-Evans Cinnamon rat
165. Elevated level of 8-hydroxydeoxyguanosine in DNA of liver, kidneys, and brain of Long-Evans Cinnamon rats
166. Two forms of Wilson disease protein produced by alternative splicing are localized in distinct cellular compartments
167. Calcium, magnesium and aluminum concentrations in Parkinson's disease
168. Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias